2 completed, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Recruiting 1 |
Follow Benign essential blepharospasm: new trials by email Literature Review of Benign essential blepharospasm trials Research Report on Benign essential blepharospasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm DaxibotulinumtoxinA - Benign Essential Blepharospasm, Hemifacial Spasm | Phase 4 | Recruiting | Montefiore Medical Center | 40 | 2025-02-11 | 2026-04-23 |
| The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm. Botulinum toxin type A - Essential Blepharospasm | Phase 4 | Completed | Hugel | 249 | 2015-04-30 | 2018-08-22 |
| Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm Botulinum Toxin Type A - Essential Blepharospasm | Phase 4 | Completed | Medy-Tox | 110 | 2010-08-01 | 2012-04-25 |
Hemifacial Spasm (1)
Mouth Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Spasm (1) · Stomatognathic Diseases (1)
Hugel (1) · Medy-Tox (1) · Montefiore Medical Center (1)
South Korea (2) · United States (1)
Anne Barmettler, MD (1) · Jaechan Kim, M.D., Ph.D. (1)
2023 (1)